View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 23, 2019

Faulty medical device alerts in UK hit four-year high

The number of alerts issued by the British Medicines and Healthcare products Regulatory Agency (MHRA) has hit a four-year high, with 35 made in the past year.

By Chloe Kent

The number of alerts issued by the British Medicines and Healthcare products Regulatory Agency (MHRA) has hit a four-year high, with 35 made in the past year.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

This is an increase from 32 last year, and more than double the 17 alerts issued three years previously.

Almost three quarters of these alerts concern Class IIb and Class III devices implanted into the body, such as pacemakers, replacement heart values and breast implants. Technologies prompting alerts included a heart monitor which risks battery packs exploding due to overheating, a blood and IV warning device which could leach unsafe levels of aluminium into a user’s bloodstream and knee joint replacements which risk early failure due to loosening parts.

London-based corporate and commercial legal firm RPC says the figures suggest a rising need for medical device manufacturers to take out specific product recall insurance.

RPC legal director Peter Rudd-Clarke said: “Product Recall insurance should be considered as a key part of medical device manufacturers’ risk management.”

Full recalls have increased proportionally to medical product recalls in general, with a number of MHRA’s alerts issued over 2018/19 involving a full product recall or instruction to destroy all remaining products.

Businesses that recall medical devices can face costs tied to shipping, storage, disposal, refunding purchasers and increased staffing costs. Insurers have begun to offer tailored product recall and contamination policies to cover these costs.

This kind of coverage is increasingly being used in addition to product liability policies, which only cover losses as a result of claims by parties who suffer injury due to a defective product.

Rudd-Clarke added: “The need for specialist product recall policies is only going to increase for medical device manufacturers over the coming years.

“A product recall can represent a huge cost to a medical device manufacturer, and much of it is not covered by a standard product liability policy.”

The Medical Devices Regulation 2017, which is due to come into full effect into 2020, will tighten the requirements for manufacturers to self-report when problems with a device are discovered.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network